Shares of HCA Healthcare, Inc. (NYSE:HCA) recorded -10.00% loss during trading session on April 16th, 2019. The script traded as low as $113.61 and last traded at $114.38. 5.14 million shares changed exchanged hands during trading, a drop of -213.16% from the 30-day average session volume of 1.64M shares. The firm had previously closed at $127.09. The company has $339.08M outstanding shares, a price-to-earnings ratio of 12.57, price-to-earnings-growth ratio of 0.83 and a beta of 0.79. The company has a RSI of 22.94, ATR of 3.48 and a volatility of 4.75% this week. HCA has a 52 week low price of $93.03 and a 52 week high price of $147.42.
Investors have identified the tech company HCA Healthcare, Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around 38.78B, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
HCA Healthcare, Inc. (HCA) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For HCA, the company has in raw cash 502 million on their books with 1.58 billion currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 0 total, with 4.57 billion as their total liabilities. This figure have given the company a good sense of viability under numerous contexts.
HCA were able to record 3.19 billion as free cash flow during the recently reported quarter of the year, this saw their quarterly net cash flow reduce by 230 million. In cash movements, the company had a total of 6.76 billion as operating cash flow.
Potential earnings growth for HCA Healthcare, Inc. (HCA)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the third quarter of the year, HCA Healthcare, Inc. recorded a total of 12.27 billion in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 0.06% coming in sequential stages and their sales for the third quarter increasing by 0.07%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 2 billion trying to sell their products during the last quarter, with the result yielding a gross income of 10.27 billion. This allows shareholders to hold on to 339.08M with the revenue now reading 3090 cents per share. This is a figure that is close to analyst’s prediction for their fourth quarter (2.53 cents a share).
Is the stock of HCA attractive?
Having a look at the company’s valuation, the company is expected to record 11.05 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on HCA sounds very interesting.
In related news, Group President Foster Jon M sold 21,304 shares of the company’s stock in a transaction that recorded on February 13th, 2019. The sale was performed at an average price of 140.89, for a total value of 3,001,435. As the sale deal closes, the CFO and EVP Foster Jon M now sold 37,500 shares of the company’s stock, valued at 5,236,691. Also, SVP & Chief Human Res. Officer STEELE JOHN M sold 33,670 shares of the company’s stock in a deal that was recorded on February 12th, 2019. The shares were sold at an average price of 140.05 per share, with a total market value of 77,734. Following this completion of acquisition, the SVP-Payer Contracting & Align. now holds 8,368 shares of the company’s stock, valued at 1,167,086. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.60%.
11 out of 28 analysts covering the stock have rated it a Buy, while 6 have maintained a Hold recommendation on HCA Healthcare, Inc. stock. 0 analysts has assigned a Sell rating on the HCA stock. The 12-month mean consensus price target for the company’s shares has been set at $153.42.